DEVELOPMENTAL FUNDS. During the current grant period, MSKCC opened the first phase of the Zuckerman Research Center. This allowed additional space for MSKCC to expand its laboratory-based cancer research efforts. An effort to attract leading laboratory-based junior investigators was begun in 2006. The strategic planning for these recruitments was undertaken by the Senior Leadership and executed by search committees led by the Program Leaders with participation from the membership. To date, 17 junior investigators have been recruited and established independent laboratories in part supported by the CCSG funds. Over the last 6 years, a total of $4.7M in developmental funds were awarded to assist in establishing their laboratories. These funds have been instrumental in the success of these junior investigators at establishing successful independent laboratories. As a group they have received $38.1M in peer-reviewed funding (total award) and produced over 80 publications from their laboratories. All 8 of the laboratory-based research programs participated in and benefited from this influx of emerging talent. Many of the new investigators brought with them expertise in new areas or techniques of relevance to the evolving scope of cancer research. Funds are now being requested to support the mission of the Cancer Center in two categories critical to the advancement of its goals: 1) Additional faculty recruitment in disciplines related to the strategic vision of the Center and 2) Pilot project grants to stimulate cross-disciplinary collaboration between investigators in the Survivorship, Outcomes and Risk (SOAR) program and members of other Cancer Center programs. Both categories represent opportunities for the Center to strengthen and diversify its research portfolio. Funds requested to support faculty recruitment in strategic areas will enable the Center to attract top talent by providing a start-up/transition package that will enable new recruits to have the resources to immediately develop and grow their research programs. Funds requested to support cross-disciplinary pilot projects between SOAR and other Cancer Center program members will provide an opportunity for the development and initiation of research projects that build upon the expertise of the Center's population scientists, as well as exploit the knowledge of the Center's basic and clinical research community in order to facilitate the discovery of new knowledge.

Public Health Relevance

The recruitment of faculty in strategic areas, as well as the initiation of pilot projects bridging population sciences with other areas of investigation are critical elements to facilitating the discovery of new cancer-related knowledge.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-52
Application #
9406238
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-01-01
Budget End
2018-12-31
Support Year
52
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Pulitzer, Melissa; Geller, Shamir; Kumar, Erica et al. (2018) T-cell receptor-? expression and ??+ T-cell infiltrates in primary cutaneous ?? T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders. Histopathology 73:653-662
Geller, Shamir; Dickson, Mark A; Busam, Klaus J et al. (2018) Kaposi's Sarcoma After Autologous Stem-Cell Transplantation and Rituximab Treatment. J Oncol Pract 14:565-568
Brand, Christian; Sadique, Ahmad; Houghton, Jacob L et al. (2018) Leveraging PET to image folate receptor ? therapy of an antibody-drug conjugate. EJNMMI Res 8:87
Jiang, Jue; Hu, Yu-Chi; Tyagi, Neelam et al. (2018) Tumor-aware, Adversarial Domain Adaptation from CT to MRI for Lung Cancer Segmentation. Med Image Comput Comput Assist Interv 11071:777-785
Cifani, Paolo; Dhabaria, Avantika; Chen, Zining et al. (2018) ProteomeGenerator: A Framework for Comprehensive Proteomics Based on de Novo Transcriptome Assembly and High-Accuracy Peptide Mass Spectral Matching. J Proteome Res 17:3681-3692
Ito, Kimiteru; Schöder, Heiko; Teng, Rebecca et al. (2018) Prognostic value of baseline metabolic tumor volume measured on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy. Eur J Nucl Med Mol Imaging :
Shah, Gunjan L; Scordo, Michael; Kosuri, Satyajit et al. (2018) Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 24:142-149
Abraham, Ann; Zhang, Alysandra J; Ahn, Rosa et al. (2018) Media Content Analysis of Marijuana's Health Effects in News Coverage. J Gen Intern Med 33:1438-1440
Maiga, Amelia W; Deppen, Stephen A; Mercaldo, Sarah Fletcher et al. (2018) Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules. JAMA Surg 153:329-334
Raj, Nitya; Reidy-Lagunes, Diane (2018) The Role of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography in Well-Differentiated Neuroendocrine Tumors: A Case-Based Approach Illustrates Potential Benefits and Challenges. Pancreas 47:1-5

Showing the most recent 10 out of 8799 publications